Nevertheless, in a structure–function-based classification of EGFR-mutant NSCLC, those with P-loop and alpha-C-helix compressing mutations in EGFR such as G719X were predicted to have inferior outcomes to third-generation EGFR TKI in silico and in vivo. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.